Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: A retrospective cohort studyResearch in context
Summary: Background: As opioid overdoses surge, medications for opioid use disorder (MOUD) remain underutilized. MOUD is rarely offered in correctional facilities although individuals involved in the criminal justice system have higher rates of OUD and mortality relative to the general population....
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-02-01
|
| Series: | The Lancet Regional Health. Americas |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667193X22002368 |
| _version_ | 1828087879486668800 |
|---|---|
| author | Rosemarie A. Martin Nicole Alexander-Scott Justin Berk Ryan W. Carpenter Augustine Kang Ariel Hoadley Eliana Kaplowitz Linda Hurley Josiah D. Rich Jennifer G. Clarke |
| author_facet | Rosemarie A. Martin Nicole Alexander-Scott Justin Berk Ryan W. Carpenter Augustine Kang Ariel Hoadley Eliana Kaplowitz Linda Hurley Josiah D. Rich Jennifer G. Clarke |
| author_sort | Rosemarie A. Martin |
| collection | DOAJ |
| description | Summary: Background: As opioid overdoses surge, medications for opioid use disorder (MOUD) remain underutilized. MOUD is rarely offered in correctional facilities although individuals involved in the criminal justice system have higher rates of OUD and mortality relative to the general population. Methods: A retrospective cohort design examined the effect of MOUD while incarcerated on 12 months post-release treatment engagement and retention, overdose mortality, and recidivism. Individuals (N = 1600) who participated in the Rhode Island Department of Corrections (RIDOC) MOUD program (the United States’ first statewide program) and were released from incarceration from December 1, 2016, to December 31, 2018, were included. The sample was 72.6% Male (27.4% female) and 80.8% White (5.8% Black, 11.4% Hispanic, 2.0% another race). Findings: 56% were prescribed methadone, 43% buprenorphine, and 1% naltrexone. During incarceration, 61% were continued on MOUD from the community, 30% were inducted onto MOUD upon incarceration, and 9% were inducted pre-release. At 30 days and 12 months post-release, 73% and 86% of participants engaged in MOUD treatment, respectively, and those newly inducted had lower post-release engagement than those who continued from the community. Reincarceration rates (52%) were similar to the general RIDOC population. Twelve overdose deaths occurred during the 12-month follow-up, with only one overdose death during the first two weeks post-release. Interpretations: Implementing MOUD in correctional facilities, with seamless linkage to community care is a needed life-saving strategy. Funding: Rhode Island General Fund, the NIH of Health HEAL Initiative, the NIGMS, and the NIDA. |
| first_indexed | 2024-04-11T05:18:24Z |
| format | Article |
| id | doaj.art-6ac8fdc4422f4e6580649528f5429b51 |
| institution | Directory Open Access Journal |
| issn | 2667-193X |
| language | English |
| last_indexed | 2024-04-11T05:18:24Z |
| publishDate | 2023-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | The Lancet Regional Health. Americas |
| spelling | doaj.art-6ac8fdc4422f4e6580649528f5429b512022-12-24T04:57:45ZengElsevierThe Lancet Regional Health. Americas2667-193X2023-02-0118100419Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: A retrospective cohort studyResearch in contextRosemarie A. Martin0Nicole Alexander-Scott1Justin Berk2Ryan W. Carpenter3Augustine Kang4Ariel Hoadley5Eliana Kaplowitz6Linda Hurley7Josiah D. Rich8Jennifer G. Clarke9Center for Alcohol and Addiction Studies, School of Public Health, Brown University, Providence, RI, USA; Corresponding author. Center for Alcohol and Addiction Studies, School of Public Health, Brown University Box G-121-5, Providence, RI, 02912, USA.Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, RI, USADepartment of Pediatrics, Warren Alpert Medical School of Brown University, Providence, RI, USADepartment of Psychological Science, University of Missouri, St. Louis, MO, USAStanford University School of Medicine, Stanford, CA, USADepartment of Social and Behavioral Sciences, Temple University, Philadelphia, PA, USAThe Center for Health and Justice Transformation, The Miriam Hospital, Providence, RI, USACODAC Behavioral Healthcare Inc., Providence, RI, USAThe Center for Health and Justice Transformation, The Miriam Hospital, Providence, RI, USA; Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USADepartment of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USASummary: Background: As opioid overdoses surge, medications for opioid use disorder (MOUD) remain underutilized. MOUD is rarely offered in correctional facilities although individuals involved in the criminal justice system have higher rates of OUD and mortality relative to the general population. Methods: A retrospective cohort design examined the effect of MOUD while incarcerated on 12 months post-release treatment engagement and retention, overdose mortality, and recidivism. Individuals (N = 1600) who participated in the Rhode Island Department of Corrections (RIDOC) MOUD program (the United States’ first statewide program) and were released from incarceration from December 1, 2016, to December 31, 2018, were included. The sample was 72.6% Male (27.4% female) and 80.8% White (5.8% Black, 11.4% Hispanic, 2.0% another race). Findings: 56% were prescribed methadone, 43% buprenorphine, and 1% naltrexone. During incarceration, 61% were continued on MOUD from the community, 30% were inducted onto MOUD upon incarceration, and 9% were inducted pre-release. At 30 days and 12 months post-release, 73% and 86% of participants engaged in MOUD treatment, respectively, and those newly inducted had lower post-release engagement than those who continued from the community. Reincarceration rates (52%) were similar to the general RIDOC population. Twelve overdose deaths occurred during the 12-month follow-up, with only one overdose death during the first two weeks post-release. Interpretations: Implementing MOUD in correctional facilities, with seamless linkage to community care is a needed life-saving strategy. Funding: Rhode Island General Fund, the NIH of Health HEAL Initiative, the NIGMS, and the NIDA.http://www.sciencedirect.com/science/article/pii/S2667193X22002368Access to careCorrectional facilitiesMedications for opioid use disorderHealth services researchOpioid use disorderIncarceration |
| spellingShingle | Rosemarie A. Martin Nicole Alexander-Scott Justin Berk Ryan W. Carpenter Augustine Kang Ariel Hoadley Eliana Kaplowitz Linda Hurley Josiah D. Rich Jennifer G. Clarke Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: A retrospective cohort studyResearch in context The Lancet Regional Health. Americas Access to care Correctional facilities Medications for opioid use disorder Health services research Opioid use disorder Incarceration |
| title | Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: A retrospective cohort studyResearch in context |
| title_full | Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: A retrospective cohort studyResearch in context |
| title_fullStr | Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: A retrospective cohort studyResearch in context |
| title_full_unstemmed | Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: A retrospective cohort studyResearch in context |
| title_short | Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: A retrospective cohort studyResearch in context |
| title_sort | post incarceration outcomes of a comprehensive statewide correctional moud program a retrospective cohort studyresearch in context |
| topic | Access to care Correctional facilities Medications for opioid use disorder Health services research Opioid use disorder Incarceration |
| url | http://www.sciencedirect.com/science/article/pii/S2667193X22002368 |
| work_keys_str_mv | AT rosemarieamartin postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT nicolealexanderscott postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT justinberk postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT ryanwcarpenter postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT augustinekang postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT arielhoadley postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT elianakaplowitz postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT lindahurley postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT josiahdrich postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext AT jennifergclarke postincarcerationoutcomesofacomprehensivestatewidecorrectionalmoudprogramaretrospectivecohortstudyresearchincontext |